NCT04527562 - Colchicine in Moderate Symptomatic COVID-19 Patients | Biotech Hunter

Enrollment

299

Participants

Timeline

Start Date

July 14, 2020

Primary Completion Date

November 15, 2020

Study Completion Date

December 10, 2020

Conditions

Covid19

Interventions

DRUG

Colchicine

Participants in this group will be given a starting dose of 1.2 mg of Colchicine (2 tablets of 0.6 mg )single or 12 hourly divided dose. After that, they will take colchicine 0.6mg daily for 13 days. If they develop gastro intestinal side effects e.g abdominal pain, burning, vomiting, diarrhea, omeprazole and antiemetic will be prescribed. Supportive care and treatment will also be given.

DRUG

Placebo

Participants in this group will be given a starting dose of 2 tablets of Placebo, single or 12 hourly divided dose. After that, they will take one placebo tablet daily for 13 days.Placebo tablet will be identical with the Colchicine tablet. If patients develop gastro intestinal side effects e.g abdominal pain, burning, vomiting, diarrhea, omeprazole and antiemetic will be prescribed. Supportive care and treatment will also be given.

Trial Locations (1)

Unknown

Dhaka Medical College Hospital, Dhaka-1000